Use of biomarkers in ALS drug development and clinical trials

Use of biomarkers in ALS drug development and clinical trials

Item
http://www.wikidata.org/entity/Q36733981
Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristicsValproate Attenuates 25-kDa C-Terminal Fragment of TDP-43-Induced Neuronal Toxicity via Suppressing Endoplasmic Reticulum Stress and Activating Autophagy.TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis.A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.Further development of biomarkers in amyotrophic lateral sclerosis.Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.Motoneuron Disease: Clinical.Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1G93A mice and modulates expression of prognosis biomarkers of the disease.
P2860

Use of biomarkers in ALS drug development and clinical trials

Item
http://www.wikidata.org/entity/Q36733981
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Use of biomarkers in ALS drug development and clinical trials
@ast
Use of biomarkers in ALS drug development and clinical trials
@en
type
label
Use of biomarkers in ALS drug development and clinical trials
@ast
Use of biomarkers in ALS drug development and clinical trials
@en
prefLabel
Use of biomarkers in ALS drug development and clinical trials
@ast
Use of biomarkers in ALS drug development and clinical trials
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Use of biomarkers in ALS drug development and clinical trials
@en
P2093
P2860
P304
P31
P356
10.1016/J.BRAINRES.2014.10.031
P407
P478
P577
P5875
P698
P921
P932